# A Study of JNJ-90009530 in Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma (r/r B-NHL)

> clinical trial · VERIFIED · 2026-07-31

Status: ACTIVE_NOT_RECRUITING · Sponsor: Janssen Research & Development, LLC · Condition: Relapsed or Refractory B Cell Non-Hodgkin Lymphoma

- Company: Janssen Research & Development, LLC
- Sector: Relapsed or Refractory B Cell Non-Hodgkin Lymphoma
- Primary source: https://clinicaltrials.gov/study/NCT05784441

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.